Literature DB >> 3824902

Detection of serum antibodies against Ehrlichia risticii in Potomac horse fever by enzyme-linked immunosorbent assay.

S K Dutta, R M Rice, T D Hughes, P K Savage, A C Myrup.   

Abstract

An indirect enzyme-linked immunosorbent assay (ELISA) was developed which was specific and sensitive in detecting antibodies to Ehrlichia risticii in Potomac horse fever (PHF). The ELISA antibody titers were correlated with the indirect fluorescent antibody (IFA) titers. E. risticii propagated in human histiocyte culture was purified on renografin gradient and the band of the organisms at a density of 1.182 g/ml was used as antigen. ELISA antibody titers were determined through computer assisted analysis, the observed antibody titers were derived by serial serum dilutions and using a resultant standard curve the predicted antibody titers were obtained from a single serum dilution. The standard curve had a correlation coefficient of 0.8975. The observed and predicted antibody titers were in good agreement, as the respective titers fell within a two-fold range. There was a good correlation between ELISA and IFA test results, but the ELISA titers were several times higher. In experimental infections of horses produced with the infected equine whole blood and the Ehrlichia infected macrophage culture, the antibodies were first detected in two weeks and one week postinoculation (PI), respectively. In both cases the titers reached a peak in about 4 weeks PI with a mean titer of 1:16558 and 1:4030, respectively. The antibody titers of the convalescent sera of field cases of PHF were comparatively lower than the experimentally infected horses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3824902     DOI: 10.1016/0165-2427(87)90077-8

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

1.  Molecular cloning of Ehrlichia risticii and development of a gene probe for the diagnosis of Potomac horse fever.

Authors:  S R Thaker; S K Dutta; S L Adhya; B L Mattingly-Napier
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Diagnostic application of polymerase chain reaction for detection of Ehrlichia risticii in equine monocytic ehrlichiosis (Potomac horse fever).

Authors:  B Biswas; D Mukherjee; B L Mattingly-Napier; S K Dutta
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Substrate utilization by Ehrlichia sennetsu and Ehrlichia risticii separated from host constituents by renografin gradient centrifugation.

Authors:  E Weiss; G A Dasch; Y H Kang; H N Westfall
Journal:  J Bacteriol       Date:  1988-11       Impact factor: 3.490

4.  Pathogenic, immunologic, and molecular differences between two Ehrlichia risticii strains.

Authors:  R Vemulapalli; B Biswas; S K Dutta
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

5.  Identification of the protective 44-kilodalton recombinant antigen of Ehrlichia risticii.

Authors:  B Shankarappa; S K Dutta; B Mattingly-Napier
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

6.  Antibody response to Ehrlichia risticii and antibody reactivity to the component antigens in horses with induced Potomac horse fever.

Authors:  S K Dutta; B L Mattingly; B Shankarappa
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Monoclonal antibody-mediated, immunodiagnostic competitive enzyme-linked immunosorbent assay for equine monocytic ehrlichiosis.

Authors:  B Shankarappa; S K Dutta; J Sanusi; B L Mattingly
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

8.  Molecular basis for antigenic variation of a protective strain-specific antigen of Ehrlichia risticii.

Authors:  B Biswas; R Vemulapalli; S K Dutta
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  Molecular cloning and analysis of recombinant major antigens of Ehrlichia risticii.

Authors:  S K Dutta; B Shankarappa; B L Mattingly-Napier
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.